Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis,European Journal of Heart Failure

当前位置： X-MOL 学术 › Eur. J. Heart Fail. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Sex differences among patients with transthyretin amyloid cardiomyopathy – from diagnosis to prognosis
European Journal of Heart Failure ( IF 16.9 ) Pub Date : 2022-08-02 , DOI: 10.1002/ejhf.2646
Rishi K Patel ₁ , Adam Ioannou ₁ , Yousuf Razvi ₁ , Liza Chacko ₁ , Lucia Venneri ₁ , Francesco Bandera _{2,

3} , Daniel Knight ₁ , Tushar Kotecha ₁ , Ana Martinez-Naharro ₁ , Ambra Masi ₁ , Aldostefano Porcari _{1,

4} , James Brown ₁ , Kiara Patel ₁ , Charlotte Manisty ₅ , James Moon ₅ , Dorota Rowczenio ₁ , Janet A Gilbertson ₁ , Gianfranco Sinagra ₄ , Helen Lachmann ₁ , Ashutosh Wechalekar ₁ , Aviva Petrie ₆ , Carol Whelan ₁ , Philip N Hawkins ₁ , Julian D Gillmore ₁ , Marianna Fontana ₁

Affiliation

Transthyretin amyloid cardiomyopathy (ATTR-CM) is predominantly diagnosed in men. The few available studies suggest affected women have a more favourable cardiac phenotype. We aimed to characterize sex differences among consecutive patients with non-hereditary and two prevalent forms of hereditary (h)ATTR-CM diagnosed over a 20-year period.

中文翻译：

转甲状腺素蛋白淀粉样心肌病患者的性别差异——从诊断到预后

运甲状腺素蛋白淀粉样心肌病 (ATTR-CM) 主要在男性中诊断。少数可用的研究表明受影响的女性具有更有利的心脏表型。我们的目的是描述 20 年来诊断出的连续患有非遗传性和两种流行形式的遗传性 (h)ATTR-CM 的患者之间的性别差异。

更新日期：2022-08-02

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11